Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan M Fogelman

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
European Heart Journal|September 18, 2015
Further evidence that high-density lipoprotein is a chameleon-like lipoproteinAlan M Fogelman
European Heart Journal|May 14, 2014
Trying to harness the potential of HDL: wishful thinking or sound strategy?Alan M Fogelman
Circulation|October 27, 2010
The complexity of high-density lipoproteinsAlan M Fogelman
Nature Medicine|September 2, 2004
When good cholesterol goes badAlan M Fogelman
Cell Metabolism|August 2, 2005
When pouring water on the fire makes it burn brighterAlan M Fogelman
Circulation Research|January 31, 2015
TMAO is both a biomarker and a renal toxinAlan M Fogelman
European Heart Journal|October 12, 2017
Making sense of a seemingly odd connectionAlan M Fogelman, Srinivasa T Reddy
Current Opinion in Lipidology|July 30, 2019
The role of the small intestine in modulating metabolism and inflammation in atherosclerosis and cancerPallavi Mukherjee, Arnab Chattopadhyay, Alan M Fogelman
Circulation Research|November 25, 2005
An apolipoprotein A-I mimetic works best in the presence of apolipoprotein A-IMohamad Navab, G M Anantharamaiah, Alan M Fogelman
Circulation Research|December 7, 2013
Protection against ischemia/reperfusion injury by high-density lipoprotein and its componentsAlan M Fogelman, Srinivasa T Reddy, Mohamad Navab
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
European Heart Journal|September 18, 2015
Further evidence that high-density lipoprotein is a chameleon-like lipoproteinAlan M Fogelman
European Heart Journal|May 14, 2014
Trying to harness the potential of HDL: wishful thinking or sound strategy?Alan M Fogelman
Circulation|October 27, 2010
The complexity of high-density lipoproteinsAlan M Fogelman
Nature Medicine|September 2, 2004
When good cholesterol goes badAlan M Fogelman
Cell Metabolism|August 2, 2005
When pouring water on the fire makes it burn brighterAlan M Fogelman
Circulation Research|January 31, 2015
TMAO is both a biomarker and a renal toxinAlan M Fogelman
European Heart Journal|October 12, 2017
Making sense of a seemingly odd connectionAlan M Fogelman, Srinivasa T Reddy
Current Opinion in Lipidology|July 30, 2019
The role of the small intestine in modulating metabolism and inflammation in atherosclerosis and cancerPallavi Mukherjee, Arnab Chattopadhyay, Alan M Fogelman
Circulation Research|November 25, 2005
An apolipoprotein A-I mimetic works best in the presence of apolipoprotein A-IMohamad Navab, G M Anantharamaiah, Alan M Fogelman
Circulation Research|December 7, 2013
Protection against ischemia/reperfusion injury by high-density lipoprotein and its componentsAlan M Fogelman, Srinivasa T Reddy, Mohamad Navab
Pageof 15